Clinical Trials Browser

Active not recruiting × OTHER × Hematologic Diseases × Clear all

Hematologic Diseases, Leukemia, Myeloid, Acute

NCT04761770 2026-02-17

Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders

Hematologic Diseases, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT03842696 2026-01-27

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

Phase 1/2 Active not recruiting

43 enrolled

LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Graft vs Host Disease, Hematologic Diseases, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT07364409 2026-01-23

ReSTORE

Phase NA Active not recruiting

5 enrolled

Azoospermia, Nonobstructive, Hematologic Diseases, Infertility, Male, Neoplasms

NCT01352520 2026-01-20

SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)

Phase 2 Active not recruiting

79 enrolled

DermatologicLymphoid

Hematologic Diseases, Lymphoma, Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous, Lymphomatoid Papulosis, Lymphoma, Primary Cutaneous Anaplastic Large Cell

NCT04062266 2026-01-13

AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission

Phase 2 Active not recruiting

50 enrolled

Other hematologic neoplasm

Hematologic Diseases, Leukemia, Myeloid, Acute

NCT04572815 2026-01-02

Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant

Phase 2 Active not recruiting

116 enrolled

Hematologic Diseases

NCT04167683 2025-12-08

Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant

Active not recruiting

144 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hematologic Diseases, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05150561 2025-08-11

Muscle Dysfunction in Patients With Haematological Diseases

Active not recruiting

216 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hematologic Diseases, Lymphoma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06849921 2025-02-27

Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors

Phase NA Active not recruiting

200 enrolled

Other hematologic neoplasm

Hematologic Diseases, Hematologic Neoplasms

NCT04786028 2025-01-08

A Study of Isatuximab Added to Standard CyBorD Induction and Lenalidomide Maintenance Treatments in ND-TEMM

Phase 2 Active not recruiting

72 enrolled

Plasma cell

Hematologic Diseases, Multiple Myeloma, Neoplasms

Clinical Trials

VENAZA-5S

Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

ReSTORE

SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)

AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission

Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant

Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant

Muscle Dysfunction in Patients With Haematological Diseases

Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors

A Study of Isatuximab Added to Standard CyBorD Induction and Lenalidomide Maintenance Treatments in ND-TEMM